American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors

CA Cancer J Clin. Jan-Feb 2007;57(1):7-28. doi: 10.3322/canjclin.57.1.7.

Abstract

The American Cancer Society (ACS) has developed guidelines for the use of the prophylactic human papillomavirus (HPV) vaccine for the prevention of cervical intraepithelial neoplasia and cervical cancer. These recommendations are based on a formal review of the available evidence. They address the use of prophylactic HPV vaccines, including who should be vaccinated and at what age, as well as a summary of policy and implementation issues. Implications for screening are also discussed.

Publication types

  • Consensus Development Conference
  • Review

MeSH terms

  • American Cancer Society
  • Female
  • Humans
  • Immunization Programs / standards*
  • Male
  • Papillomavirus Infections / pathology
  • Papillomavirus Infections / prevention & control*
  • Papillomavirus Vaccines / therapeutic use*
  • Practice Guidelines as Topic*
  • Precancerous Conditions / pathology
  • Precancerous Conditions / prevention & control*
  • Precancerous Conditions / virology
  • Preventive Medicine / standards*
  • United States
  • Uterine Cervical Neoplasms / prevention & control*
  • Uterine Cervical Neoplasms / virology

Substances

  • Papillomavirus Vaccines